At Cromos Pharma we have built up extensive expertise in orphan drug research and developed solutions to overcome some of key challenges in this area. Our expert team has contributed to the analysis, design, management and/or conduct of 20+ studies in rare diseases, covering Phases II to IV. You can learn more by visiting our website here.
We would be pleased to discuss our experience and opportunities for collaboration at the upcoming Congress. You can register here to connect via the event’s dedicated partnering program or email us at email@example.com to set up a virtual meeting.
You can follow all the latest at the event via Twitter @orphan_drugs and post using
We look forward to meeting you!